Find

Search Newsmax Health Search Newsmax Search Web
Newsletters Video Shop Contact Us Archives
 
Newsmax Moneynews Newsmax.TV
 
 
Health Stories  

Hormone Linked to Addiction, Risk-Taking

Tuesday, February 2, 2010 8:06 AM

Print this Page  

Forward Page  Forward Page

Email Us  Email Us

People with high levels of the hormone dopamine in the brain, and low sensitivity to it, tend to be greater risk takers and may be more prone to addictive behavior, drug abuse, and gambling, a study has found.

Scientists from Denmark and Japan said they had proved in research that a need for stimulation is greater on average among those who have more of the gratification hormone, dopamine, in their brains, partly because of their lower sensitivity to it.

The study by Albert Gjedde of Copenhagen University, and published in the Proceedings of the National Academy of Sciences (PNAS) journal on Monday, scanned the brains of healthy volunteers to look at dopamine and dopamine receptor levels.

"People at the higher end of the scale get less effect from the same amount of dopamine as people lower on the scale, until they get so low in dopamine that there is too little...to have an effect," Gjedde told Reuters in an email.

The findings could help scientists develop ways to prevent or treat addictive behavior, they said, and throw new light on drug approaches to conditions like attention deficit hyperactivity disorder, commonly called ADHD.

The researchers said their findings showed people at the low and high ends of the scale have very different dopamine and dopamine receptor profiles, suggesting it may be better to try to increase or decrease levels of the dopamine itself, rather than to block the receptors.

Drugs like AstraZeneca's Seroquel and Eli Lilly's Zyprexa, which belong to a class of drugs known as antipsychotics, work by blocking the action of dopamine in the brain.

They are approved for mental illnesses such as depressions, schizophrenia, and bipolar disorder but are also increasingly prescribed for children with ADHD.

© 2010 Reuters. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters.

 

 
 
   
   
   
       Privacy Policy  |  Terms & conditions  |  Contact Us

PLEASE NOTE: All information presented in Newsmaxhealth.com and Newsmax.com is for informational purposes only. It is not specific medical advice for any individual. All answers to reader questions are provided for informational purposes only. All information presented on our websites should not be construed as medical consultation or instruction. You should take no action solely on the basis of this publication’s contents. Readers are advised to consult a health professional about any issue regarding their health and well-being. While the information found on our websites is believed to be sensible and accurate based on the author’s best judgment, readers who fail to seek counsel from appropriate health professionals assume risk of any potential ill effects. The opinions expressed in Newsmaxhealth.com and Newsmax.com do not necessarily reflect those of Newsmax Media. Please note that this advice is generic and not specific to any individual. You should consult with your doctor before undertaking any medical or nutritional course of action